BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29909471)

  • 1. PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
    Nguyen TT; Lange NGE; Nielsen AL; Thomassen A; Døssing H; Godballe C; Rohde M
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2109-2117. PubMed ID: 29909471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
    Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.
    Kim SJ; Chang S
    Endocrine; 2015 Dec; 50(3):681-8. PubMed ID: 25948075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Merten MM; Castro MR; Zhang J; Durski J; Ryder M
    Thyroid; 2017 Jan; 27(1):95-102. PubMed ID: 27762671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
    Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between positron emission tomography-computed tomography imaging and histopathological features of thyroid incidentalomas detected during follow-up for primary malignancy.
    Oven BB; Kilicoglu ZG; Bilici A; Tatoglu MT; Canberk S; Tilki M; Vardar FA
    J Cancer Res Ther; 2019; 15(3):589-595. PubMed ID: 31169225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy anddiagnostic value of thyroid scintigraphy and
    Almasi CE; Frandsen AP; Erentaite D; Duch K; Zacho HD
    Hell J Nucl Med; 2023; 26(1):2-8. PubMed ID: 37031417
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L; Suriano S; Maffioli M; Ceriani L
    Clin Endocrinol (Oxf); 2011 May; 74(5):644-8. PubMed ID: 21470288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration in all thyroid incidentalomas at
    Trimboli P; Paone G; Treglia G; Virili C; Ruberto T; Ceriani L; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):642-648. PubMed ID: 30019402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Malignancy in FDG-Avid Thyroid Incidentalomas on PET/CT: A Prospective Study.
    Abdel-Halim CN; Rosenberg T; Bjørndal K; Madsen AR; Jakobsen J; Døssing H; Bay M; Thomassen A; Nielsen AL; Godballe C
    World J Surg; 2019 Oct; 43(10):2454-2458. PubMed ID: 31161354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.